Botox could be effective against some common sports injuries

While botulinum toxin is usually commonly known as a cosmetic treatment for facial lines and wrinkles, a growing body of evidence suggests that “Botox” can also be an effective treatment for certain sports injuries and chronic pain conditions, according to an examine in the June issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine (ACSM). The journal can be published in the Lippincott portfolio by Wolters Kluwer.

Clint Moore, DO, and colleagues of the Uniformed Services University of the Health Sciences assembled and analyzed earlier study on the use of botulinum toxin A (BoNT-A) — best known by the brand name Botox comestic injection – for treatment of musculoskeletal disorders.

We found out evidence teaching promising pain alleviation and functional improvements applying botulinum toxin for some very common conditions, including otorgar fasciopathy, rugby elbow, and then painful knee osteoarthritis, Dr . Moore feedback.

Numerous different kinds of BoNT-A are available, yet most act about motor neurons (nerve cells) to create muscle weakness and about sensory neurons to prevent the release of pain modulators. As in cosmetic methods, finally, the effects of BoNT-A injection are time-limited, and cure may need to become repeated for sustained rewards. The effects on muscle mass contraction last about three weeks, while effects on pain may last for 6 weeks.

In a critical evaluation of the research literature, Dr . Moore and colleagues recognized studies showing that the neuromuscular blockade offered by BoNT-A can reduce pain and then improve function in several musculoskeletal conditions including Otorgar fasciopathy, Osteoarthritis, Lateral epicondylitis and Chronic exertional area syndrome.

For each of these circumstances, Dr . Moore and colleagues discuss the part in BoNT-A and how they use it in their practice, including injection technique and dose. Their paper also evaluations studies applying BoNT-A for individuals by way of myofascial pain syndrome, a good relatively common cause in chronic pain – by way of inconclusive results.